| Literature DB >> 36231943 |
Renata Gonçalves Pinheiro Correa1, Anna Raquel Silveira Gomes2, Victoria Zeghbi Cochenski Borba3.
Abstract
INTRODUCTION: Elderly women with osteoporosis are at risk of falls and fractures.Entities:
Keywords: elderly; falls; fractures; intrinsic factors; osteoporosis; treatment
Mesh:
Year: 2022 PMID: 36231943 PMCID: PMC9564876 DOI: 10.3390/ijerph191912643
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flow diagram of the selection of the study participants. TG, treatment group; CG, control group; TBS, trabecular bone score; MMSE, mini-mental state examination; TUG, timed up and go test; GS, gait speed; SST, sit-to-stand test; HGS, hand-grip strength; SPPB, short physical profile battery; PPA, physiological profile assessment; ROM, range of motion.
Anthropometric data of patients and controls.
| Variables | TG ( | CG ( |
|
|---|---|---|---|
| Age (years) | 71.98 ± 3.47 | 71.13 ± 2.41 | 0.113 |
| Race | |||
| White | 88.23% ( | 98.33% ( | 0.577 |
| Black | 11.70% ( | 1.66% ( | 0.600 |
| Height (m) | 1.54 ± 0.06 | 1.58 ± 0.08 | 0.002 |
| Weight (Kg) | 64.13 ± 11.13 | 68.85 ± 10.54 | 0.015 |
| BMI (kg/m2) | 26.52 ± 3.71 | 21.77 ± 3.35 | <0.000 |
| Underweight | - | 16.70% ( | <0.000 |
| Normal | 41.17% ( | 56.70% ( | <0.000 |
| Pre-obese | 38.23% ( | 23.40% ( | <0.000 |
| Obese | 20.59% ( | - | <0.000 |
| Comorbidities (N) | 1.46 ± 1.30 | 0.76 ± 0.96 | <0.000 |
| Hypertension | 46.37% ( | 53.33% ( | 0.246 |
| Hyperglycemia | 79.71% ( | 76.66% ( | 0.855 |
| Dyslipidemia | 60.86% ( | 43.33% ( | 0.085 |
| DM2 | 79.71% ( | 76.65% ( | 0.855 |
| Medications (N) | 4.10 ± 2.96 | 2.30 ± 2.56 | 0.000 |
| Osteoporosis treatment | |||
| Alendronate | 50.0% ( | - | |
| Risedronate | 2.94% ( | - | |
| Pamidronate | 23.53% ( | - | |
| Zoledronic acid | 2.94 % ( | - | |
| No treatment # | 20.59% ( | - | |
| Treatment time (years) | 1.94 ± 4.38 | - | |
| BMD (g/m2) | |||
| Spine | 0.768 ± 0.13 | 0.901 ± 0.19 | <0.000 |
| Femoral neck | 0.647 ± 0.90 | 0.715 ± 0.27 | 0.057 |
| Total hip | 0.748 ± 0.11 | 0.693 ± 0.15 | 0.023 |
| BMD classification | |||
| Normal | 2.90% ( | 21.70% ( | <0.000 |
| Osteopenia | 20.30% ( | 58.30% ( | <0.000 |
| Osteoporosis | 76.80% ( | 20.00% ( | <0.000 |
| Low | 97.10% ( | 78.30% ( | <0.000 |
| TBS score | 1.23 ± 0.10 | 1.30 ± 0.14 | 0.001 |
| Normal | 30.00% ( | 56.60% ( | <0.000 |
| Partially degraded | 38.60% ( | 23.30% ( | <0.000 |
| Degraded | 41.40% ( | 20.00% ( | <0.000 |
| Past fracture % (N) | 15.30% ( | 13.50% ( | 0.455 |
| 1 | 13.40% ( | 11.40% ( | 0.142 |
| ≥2 | 1.10% ( | 0.90% ( | 0.142 |
| Falls classification | |||
| Non-faller | 78.5% ( | 81% ( | 0.866 |
| Faller | 16.5% ( | 11%( | 0.866 |
| Recurrent faller | 5% ( | 6% ( | 0.866 |
| MMSE | 26.50 ± 3.11 | 27.96 ± 1.62 | 0.001 |
Abbreviations: values expressed as mean ± standard deviation, relative (%) and absolute (numbers) frequencies; TG: treatment group; CG: control group; BMI: body mass index; DM2: type-2 diabetes melitus; BMD: bone mineral density; TBS: trabecular bone scores; MMSE: mini-mental state examination; # no treatment at the moment.
Intrinsic factors for falls in the treatment and control groups.
| Variables | TG ( | CG( |
| ||
|---|---|---|---|---|---|
| Mean ± SD | Cohen D | Mean ± SD | Cohen D | ||
|
| |||||
| TUG (s) | 10.06 ± 2.70 | 2.2 | 11.43 ± 3.04 | 0.48 | 0.008 |
| Reduced (<9.2 s) | 61.4% ( | 75.9% ( | 0.090 | ||
| GS (s) | 0.90 ± 0.17 | 4.11 | 0.81 ± 0.14 | 0.58 | 0.004 |
| Low (≤0.8 m/s) | 74.3% ( | 46.6% ( | 0.001 | ||
| SPPB (score) | 9.30 ± 2.40 | 4.87 | 7.88 ± 1.36 | 0.72 | 0.000 |
| 0 (worst performance) | |||||
| 12 (best performance) | |||||
|
| |||||
| SST (s) | 12.30 ± 2.74 | 0.3 | 12.79 ± 3.10 | 0.17 | 0.343 |
| Low (%) | 45.7% ( | 41.4% ( | 0.182 | ||
| HGS (kgf) | 21.24 ± 3.78 | 4.62 | 22.46 ± 4.24 | 0.31 | 0.087 |
| Low (≤18 kgf) | 11.4% ( | 8.6% ( | 0.174 | ||
|
| 0.06 | 0 | |||
| Dorsiflexors | 22.16 ± 6.10 | 21.98 ± 4.09 | 0.8 | 0.989 | |
| Low (<26 ± 6.3°) | 100% | 100% | 1 | ||
| Plantiflexors | 46.46 ± 7.17 | 4.13 | 41.23 ± 5.86 | 0.55 | 0.001 |
| Low (<57 ± 7.2°) | 100% | 100% | 1 | ||
|
| |||||
| Medial gastrocnemius | |||||
| MT | 1.40 ± 0.23 | 11.23 | 1.37 ± 0.26 | 0.12 | 0.452 |
| FL | 4.43 ± 0.88 | 4.61 | 4.36 ±0.97 | 0.08 | 0.686 |
| PA | 19.09 ± 4.70 | 4.24 | 20.45 ± 4.36 | 0.3 | 0.092 |
| PIS—ankle | |||||
| Dorsiflexion | 7.78 ± 2.96 | 3.47 | 8.23 ± 1.21 | 0.2 | 0.275 |
| Plantarflexion | 10.41 ± 4.19 | 0.69 | 11.87± 2.45 | 0.42 | 0.019 |
Values expressed as mean ± standard deviation, relative (%) and absolute (numbers) frequencies; TG, treatment group; CG, control group; TUG, timed up and go test; s, seconds; TUG normal values by age: 60–69 years: 8.1 s (s), 70–79 years: 9.2 s, ≥80 years or older: 11.3 s; GS, gait speed; m, meters; SPPB, short physical performance battery; SST, sit-to-stand test; SST normal values by age: 60–69 years: 11.4 s, 70–79 years: 12.6 s, 80–89 years: 12.7 s; HGS, hand-grip strength; kgf, kilogram force; ROM, range of motion, MT, muscle thickness; FL, fascicle length; PA, pennation angle; MG, medial gastrocnemius; PIS, peak isometric strength.
Physiological profile assessment stratification of falls.
| TG ( | D-Cohen | CG ( |
| Cohen-D | |
|---|---|---|---|---|---|
| Visual contrast | 16.92 ± 2.15 | 2.22 | 17.21 ± 1.57 | 0.391 | 0.15 |
| Excellent/good | 8.6% ( | 1.6% ( | 0.047 | ||
| Fair/bad | 91.30% ( | 93.3% ( | 0.046 | ||
| Proprioception | 2.51 ± 1.54 | 9.53 | 1.80 ± 0.90 | 0.002 | 0.56 |
| Good/fair | 84.05% ( | 95.00% ( | 0.018 | ||
| Bad | 11.94% ( | 5.00% ( | 0.018 | ||
| Strength LM | 23.82 ± 5.82 | 5.16 | 27.60 ± 6.17 | 0.001 | 0.67 |
| Excellent/good | 69.56% ( | 93.33% ( | 0.002 | ||
| Fair/bad | 30.43% ( | 6.66% ( | 0.003 | ||
| Reaction time | 391.04 ± 111.59 | 4.48 | 394.86 ± 109.40 | 1 | 0.03 |
| Excellent/good | 17.39%( | 18.33% ( | 1 | ||
| Fair/bad | 82.60%( | 81.66% ( | 1 | ||
| Postural sway | 322.60 ± 147.99 | 0.55 | 319.33 ± 157.60 | 0.564 | 0.02 |
| Excellent/good | 100.00% ( | 98.33% ( | 0.166 | ||
| Falls risk | 2.22 ± 1.17 | 2.98 | 1.56 ± 0.94 | 0.050 | 0.62 |
| Very low | 5.7% ( | 26.66% ( | 0.003 | ||
| Low | 73.91% ( | 65.00% ( | 0.002 | ||
| Moderate/very high | 14.49% ( | 5.00% ( | 0.002 |
Values expressed as mean ± standard deviation, relative (%) and absolute (numbers) frequencies; TG, treatment group; CG, control group; LM, lower members.